Excel Venture Management

Type

Venture Capital

Status

Active

Location

Boston, United States

Total investments

67

Average round size

12M

Portfolio companies

44

Rounds per year

4.19

Lead investments

9

Follow on index

0.34

Exits

26

Stages of investment
SeedEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologySoftwareInformation TechnologyHealth CareHealth DiagnosticsMedical DeviceMedicalCloud Data ServicesPharmaceuticalTherapeutics

Summary

In 2008 was created Excel Venture Management, which is appeared as VC. The leading representative office of defined VC is situated in the Boston. The company was established in North America in United States.

The usual cause for the fund is to invest in rounds with 4 partakers. Despite the Excel Venture Management, startups are often financed by Novartis Venture Fund, LaunchPad Venture Group, HLM Venture Partners. The meaningful sponsors for the fund in investment in the same round are HLM Venture Partners, Merck Global Health Innovation Fund, SR One. In the next rounds fund is usually obtained by Merck Global Health Innovation Fund, HLM Venture Partners, SR One.

This Excel Venture Management works on 6 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 27 percentage points more often commits exit comparing to other organizations. The top activity for fund was in 2011. Despite it in 2019 the fund had an activity. The fund is generally included in 2-6 deals every year. The higher amount of exits for fund were in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Biopharma, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight Cleveland HeartLab, IlluminOss Medical, Saladax Biomedical. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low.

The overall number of key employees were 6.

Show more

Investor highlights

Industry focus
MedtechHealthcareBiotech/Life SciencesAgricultureEnergy Show 2 more
Check size
1M — 5M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
67
Lead investments
9
Exits
26
Rounds per year
4.19
Follow on index
0.34
Investments by industry
  • Health Care (45)
  • Biotechnology (29)
  • Medical (13)
  • Information Technology (12)
  • Software (12)
  • Show 46 more
Investments by region
  • United States (65)
  • Canada (2)
Peak activity year
2011
Number of Unicorns
1
Number of Decacorns
1
Number of Minotaurs
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
68M
Group Appearance index
0.78
Avg. company exit year
11
Avg. multiplicator
0.84
Strategy success index
0.60

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
ChAI 05 May 2021 Software, Information Technology, Artificial Intelligence, Machine Learning, Manufacturing Seed England, London, United Kingdom
Cleveland HeartLab 22 Aug 2011 Biotechnology, Health Care, Medical Device, Life Science Early Stage Venture 18M United States, Ohio, Cleveland
nextProtein 27 May 2020 Biotechnology, Animal Feed, Agriculture Early Stage Venture 12M Ile-de-France, Paris, France
Springleaf Therapeutics 08 Jul 2011 Biotechnology, Therapeutics, Biopharma Early Stage Venture 19M United States, Massachusetts, Boston

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.